Mark Layton Email
Vice President in Development and MDL Otilimab @ GSK
5 free lookup(s).
No credit card required.
Mark Layton Location
- London, GB
Mark Layton Work
- 2015 -now Vice President in Development and MDL Otilimab @
- 2012 -2015 Head of Discovery Medicine, Immunoinflammation Tau @
- 2006 -2012 Medical Science Director @
- 2008 -2012 Fellow @ FPM
- 2003 -2005 Clinical Expert @ Celltech
- 2000 -2003 Global Clinical Leader @
- 1999 -2000 New Business Development Medical Manager @
- 1998 -1999 Medical Affairs Manager @
- 1989 -1998 NHS Positions, Clinical and Research @
Mark Layton Education
- University of Nottingham
Bachelor of Science (Medicine)
1984-1989
Mark Layton Skills
- Clinical Research
- Clinical Trials
- Medical Affairs
- Clinical Development
- Drug Development
- Pharmaceutical Industry
- Medicine
- Infectious Diseases
- Oncology
- Life Sciences
- Pharmacovigilance
- Medical Writing
- Biotechnology
- CRO
- GCP
- R&d
- CRO Management
- Good Clinical Practice Gcp
- Good Clinical Practice
Mark Layton Summary
- Mark Layton, based in London, GB, is currently a Vice President in Development and MDL Otilimab at GSK. Mark Layton brings experience from previous roles at GSK, Astrazeneca, FPM and Celltech. Mark Layton holds a 1984 - 1989 Bachelor of Science in Medicine @ University of Nottingham. With a robust skill set that includes Clinical Research, Clinical Trials, Medical Affairs, Clinical Development, Drug Development and more. Mark Layton has 2 emails on RocketReach.
5 free lookup(s).
No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
Looking for a different Mark Layton?
Find contact details for 700 million professionals.
Others Named Mark Layton
Mark Layton
Instructor II - Professor
Texas, United States
Mark Layton
Managing Member
Las Vegas, NV, US
Mark Layton
Sr. Plant Director
Kansas City, MO, US
Mark Layton
Senior Principal Scientist
West Point, PA, US
Mark Layton
Chief Financial Officer, Chief Compliance Officer and Secretary
Oklahoma City, OK, US
Top GSK Employees
Alison Farquhar
VP, Vaccines Commercialization Leader mRNA Next Gen Covid-19 Vaccine
Little Kingshill, GB
James Ford
Senior Vice President and Group General Counsel
United Kingdom
Andre Vivan
SVP E2E Global Marketing
United Kingdom
Luke Miels
Chief Executive Officer
London, GB
Phil Thomson
President, Global Affairs
London, England, GB
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups.
Search the #1 Contact Database
Get contact details of over 700M profiles across 60M companies - all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co